Mood stabilizers in pregnancy: A systematic review

Australian and New Zealand Journal of Psychiatry

Volumn 44, Issue 11, 2010, Pages 967-977

  Galbally, Megan ^a   Roberts, Matthew ^b   Buist, Anne ^c  

^a MERCY HOSPITAL FOR WOMEN   (Australia)

^b O'Connell Family Centre   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

anti epileptic drugs; lithium carbonate; mood stabilizers; pregnancy

Indexed keywords

CARBAMAZEPINE; LAMOTRIGINE; LITHIUM CARBONATE; VALPROIC ACID;

ANENCEPHALUS; BIPOLAR DISORDER; BIRTH WEIGHT; COCHRANE LIBRARY; CONGENITAL HEART DISEASE; DISEASE ASSOCIATION; DRUG EXPOSURE; EBSTEIN ANOMALY; EMBASE; HUMAN; HYPOGLYCEMIA; INFORMATION; INTELLIGENCE QUOTIENT; IRRITABILITY; KIDNEY CLEARANCE; MATERNAL CARE; MEDLINE; MICROCEPHALY; MUSCLE HYPERTONIA; NEWBORN DISEASE; OUTCOME ASSESSMENT; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PSYCINFO; RELAPSE; REVIEW; RISK FACTOR; SEIZURE; SIDE EFFECT; STILLBIRTH; SYSTEMATIC REVIEW; TERATOGENICITY; VOMITING;

ABNORMALITIES, DRUG-INDUCED; ANTIDEPRESSIVE AGENTS; ANTIMANIC AGENTS; BIPOLAR DISORDER; CARBAMAZEPINE; FEMALE; HUMANS; LITHIUM CARBONATE; MOOD DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PSYCHOTROPIC DRUGS; TRIAZINES;

EID: 78049519301     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.3109/00048674.2010.506637     Document Type: Review

References (92)

1. Yatham LN, Kennedy SH, Schaffer A et al . Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bip Disorder 2009; 11:225-255.
2. Derby IM. Manic-depressive ' exhaustion ' deaths. P sychiatric Quarterly 1933; 7:435-439.
3. Judd LL, Akiskal HS, Schettler PJ e t al . The long-term natural history of the weekly symptomatic status of bipolar disorder. Arch Gen Psychiatry 2002; 59:530-537.
4. Viguera AC, Whitfi eld T, Baldessarini RJ et al . Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. Am J Psychiatry 2007; 164:1817-1824; quiz 923.
5. Viguera AC, Nonacs R, Cohen LS, Tondo L, Murray A, Baldessarini RJ. Risk of recurrence of bipolar disorder in pregnant and non-pregnant women after discontinuing lithium maintenance. Am J Psychiatry 2000; 157:179-184.
6. Stewart DE, Klompenhouwer JL, Kendell RE, van Hulst AM. Prophylactic lithium in puerperal psychosis. The experience of three centres. Br J Psychiatry 1991; 158:393-397.
7. Wan MW, Salmon MP, Riordan DM, Appleby L, Webb R, Abel KM. What predicts poor mother - infant interaction in schizophrenia? Psychol Med 2007; 37:537-546.
8. Murray L, Sinclair D, Cooper PA, Ducournau P, Turner P. The socio emotional development of 5-year-old children of postnatally depressed mothers. J Child Psychol Psychiatry 1999; 40: 1259-1271.
9. O ' Connor TG, Ben-Shlomo Y, Heron J, Golding J, Adams D, Glover V. Prenatal anxiety predicts individual differences in cortisol in pre-adolescent children. Biol Psychiatry 2005; 58:211-217.
10. Murray L, Fiori-Cowley A, Hooper R, Cooper P. The impact of postnatal depression and associated adversity on early mother - infant interactions and later infant outcome. Child Dev 1996; 67:2512- 2 526.
11. Einarson A, Boskovic R. Use and safety of antipsychotic drugs during pregnancy. J Psychiatr Pract 2009; 15:183-192.
12. Gentile S. Clinical utilization of atypical antipsychotics in pregnancy and lactation. Ann Pharmacother 2004; 38:1265-1271.
13. Gentile S. Prophylactic treatment of bipolar disorder in pregnancy and breastfeeding: focus on emerging mood stabilizers. Bip Disord 2006; 8:207-220.
14. Adab N, Tudur Smith C, Vinten J, Williamson PR, Winterbottom JB. Common antiepileptic drugs in pregnancy in women with epilepsy. Cochrane Data Syst Rev 2004.
15. Jones KL, Lacro RV, Johnson KA, Adams J. Pattern of malformations in the children of women treated with carbamazepine during pregnancy. N Engl J Med 1989; 320:1661-1666.
16. Dravet C, Julian C, Legras C et al . Epilepsy, antiepileptic drugs, and malformations in children of women with epilepsy: a French prospective cohort study. Neurology 1992;42:S75 - 82.
17. Tanganelli P, Regesta G. Epilepsy, pregnancy, and major birth anomalies: an Italian prospective, controlled study. Neurology 1992; 42:S89 - 93.
18. Omtzigt JG, Los FJ, Grobbee DE et al . The risk of spina bifi da aperta after fi rst-trimester exposure to valproate in a prenatal cohort. Neurology 1992; 42:S119 - 125.
19. Steegers-Theunissen RP, Renier WO, Borm GF e t al . Factors infl uencing the risk of abnormal pregnancy outcome in epileptic women: a multi-centre prospective study. Epilepsy Res 1994; 18:261-269.
20. Kaneko S, Battino D, Andermann E et al . Congenital malformations due to antiepileptic drugs. Epilepsy Res 1999; 33:145-158.
21. Canger R, Battino D, Canevini MP e t al . Malformations in offspring of women with epilepsy: a prospective study. Epilepsia 1999; 40:1231-1236.
22. Lindhout D, Schmidt D. In utero exposure to valproate and neural tube defects. Lancet 1986; 1:1392-1393.
23. Rodriguez-Pinilla E, Arroyo I, Fondevilla J, Garcia MJ, Martinez- Frias ML. Prenatal exposure to valproic acid during pregnancy and limb defi ciencies: a case - control study. Am J Med Genet 2000; 90:376-381.
24. Arpino C, Brescianini S, Robert E e t al . Teratogenic effects of antiepileptic drugs: use of an International Database on Malformations and Drug Exposure (MADRE). Epilepsia 2000; 41:1436-1443.
25. Diav-Citrin O, Shechtman S, Arnon J, Ornoy A. Is carbamazepine teratogenic? A prospective controlled study of 210 pregnancies. Neurology 2001; 57:321-324.
26. Kaaja E, Kaaja R, Hiilesmaa V. Major malformations in offspring of women with epilepsy. Neurology 2003; 60:575-579.
27. Wyszynski DF, Nambisan M, Surve T, Alsdorf RM, Smith CR, Holmes LB. Increased rate of major malformations in offspring exposed to valproate during pregnancy. Neurology 2005; 64:961-965.
28. Meador KJ, Baker GA, Finnell RH et al . In utero antiepileptic drug exposure: fetal death and malformations. Neurology 2006; 67:407-412.
29. Morrow J, Russell A, Guthrie E e t al . Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 2006; 77:193-198.
30. Puho EH, Szunyogh M, Metneki Jl, Czeizel AE. Drug treatment during pregnancy and isolated orofacial clefts in hungary. Cleft Palate Craniofac J 2007; 44:194-202.
31. Cunnington M, Ferber S, Quartey G. Effect of dose on the frequency of major birth defects following fetal exposure to lamotrigine monotherapy in an international observational study. Epilepsia 2007; 48:1207-1210.
32. Kini U, Lee R, Jones A e t al . Infl uence of the MTHFR genotype on the rate of malformations following exposure to antiepileptic drugs in utero. Eur J Med Genet 2007; 50:411-420.
33. Vajda FJE, Hitchcock A, Graham J, O' Brien T, Lander C, Eadie M. The Australian Register of Antiepileptic Drugs in Pregnancy: the fi rst 1002 pregnancies. Aust N Z J Obstet Gynaecol 2007; 47:468-474. (Pubitemid 350075922)
34. Holmes LB, Baldwin EJ, Smith CR et al . Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancy. Neurology 2008; 70:2152-2158.
35. Diav-Citrin O, Shechtman S, Bar-Oz B, Cantrell D, Arnon J, Ornoy A. Pregnancy outcome after in utero exposure to valproate: evidence of dose relationship in teratogenic effect. CNS Drugs 2008; 22:325-334.
36. Thomas SV, Ajaykumar B, Sindhu K e t al . Cardiac malformations are increased in infants of mothers with epilepsy. Pediatr Cardiol 2008; 29:604-608.
37. Dolk H, Jentink J, Loane M, Morris J, de Jong-van den Berg LTW. Does lamotrigine use in pregnancy increase orofacial cleft risk relative to other malformations? Neurology 2008; 71:714-722.
38. Morrow J, Russell A, Guthrie E et al . Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 2006; 77:193-198.
39. Walker SP, Permezel M, Berkovic SF. The management of epilepsy in pregnancy. BJOG 2009; 116:758-767.
40. Meador KJ, Reynolds MW, Crean S, Fahrbach K, Probst C. Pregnancy outcomes in women with epilepsy: a systematic review and meta-analysis of published pregnancy registries and cohorts. Epilepsy Res 2008; 81:1-13.
41. Nau H, Rating D, Koch S, Hauser I, Helge H. Valproic acid and its metabolites: placental transfer, neonatal pharmacokinetics, transfer via mother ' s milk and clinical status in neonates of epileptic mothers. J Pharmacol Exp Ther 1981; 219:768-777.
42. Hiilesmaa VK, Teramo K, Granstrom ML, Bardy AH. Fetal head growth retardation associated with maternal antiepileptic drugs.Lancet 1981; 2:165-167.
43. Koch S, Gopfert-Geyer I, Hauser I et al . Neonatal behaviour disturbances in infants of epileptic women treated during pregnancy. Prog Clin Biol Res 1985; 163B:453-461.
44. Gaily E, Granstrom ML. A transient retardation of early postnatal growth in drug-exposed children of epileptic mothers. Epilepsy Res 1989; 4:147-155.
45. Gaily EK, Granstrom ML, Hiilesmaa VK, Bardy AH. Head circumference in children of epileptic mothers: contributions of drug exposure and genetic background. Epilepsy Res 1990; 5:217-222.
46. Yerby MS, Leavitt A, Erickson DM e t al . Antiepileptics and the development of congenital anomalies. Neurology 1992; 42:S132- 140.
47. Nulman I, Scolnik D, Chitayat D, Farkas LD, Koren G. Findings in children exposed in utero to phenytoin and carbamazepine monotherapy: independent effects of epilepsy and medications. Am J Med Genet 1997; 68:18-24.
48. Wide K, Winbladh B, Tomson T, Kallen B. Body dimensions of infants exposed to antiepileptic drugs in utero: observations spanning 25 years. Epilepsia 2000; 41:854-861.
49. Hvas CL, Henriksen TB, Ostergaard JR, Dam M. Epilepsy and pregnancy: effect of antiepileptic drugs and lifestyle on birthweight. Br J Obstet Gynaecol 2000; 107:896-902.
50. Ebbesen F, Joergensen A, Hoseth E e t al . Neonatal hypoglycaemia and withdrawal symptoms after exposure in utero to valproate. Arch Dis Child Fetal Neonatal Ed 2000; 83:F124 - 129.
51. Kaaja E, Kaaja R, Matila R, Hiilesmaa V. Enzyme-inducing antiepileptic drugs in pregnancy and the risk of bleeding in the neonate. Neurology 2002; 58:549-553.
52. Meador KJ, Baker GA, Browning N e t al . Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med 2009; 360:1597-1605.
53. Gaily E, Kantola-Sorsa E, Hiilesmaa V et al . Normal intelligence in children with prenatal exposure to carbamazepine. Neurology 2004; 62:28-32.
54. Holmes LB, Coull BA, Dorfman J, Rosenberger PB. The correlation of defi cits in IQ with midface and digit hypoplasia in children exposed in utero to anticonvulsant drugs. J Pediatr 2005; 146: 118-122.
55. Eriksson K, Viinikainen K, Monkkonen A e t al . Children exposed to valproate in utero-population based evaluation of risks and confounding factors for long-term neurocognitive development. Epilepsy Res 2005; 65:189-200.
56. Viinikainen K, Eriksson K, Monkkonen A e t al . The effects of valproate exposure in utero on behavior and the need for educational support in school-aged children. Epilepsy Behav 2006; 9:636-640.
57. Titze K, Koch S, Helge H, Lehmkuhl U, Rauh H, Steinhausen H-C. Prenatal and family risks of children born to mothers with epilepsy: effects on cognitive development. Dev Med Child Neurol 2008; 50:117-122.
58. Vinten J, Adab N, Kini U, Gorry J, Gregg J, Baker GA. Neuropsychological effects of exposure to anticonvulsant medication in utero. Neurology 2005; 64:949-954.
59. Kantola-Sorsa E, Gaily E, Isoaho M, Korkman. Neuropsychological outcomes in children of mothers with epilepsy. J Int Neurospsychol Soc 2007; 13:642-652.
60. Adab N, Kini U, Vinten J et al . The longer term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 2004; 75:1575-1583.
61. Thomas SV, Ajaykumar B, Sindhu K, Nair MKC, George B, Sarma PS. Motor and mental development of infants exposed to antiepileptic drugs in utero . Epilepsy Behav 2008; 13:229-236.
62. Vinten J, Bromley RL, Taylor JT, Adab N, Kini U, Baker G. The behavioural consequences of exposure to antiepileptic drugs in utero . Epilepsy Behav 2009; 14:197-201.
63. Rasalam AD, Hailey H, Williams JHG, Moore SJ, Turnpenny P, Lloyd DJ, et al . Characteristics of fetal anticonvulsant syndrome associated autistic disorder. Dev Med Child Neurol 2005; 47: 551-555.
64. Thomas SV, Sukumaran S, Lukose N, George A, Sarma PS. Intellectual and language functions in children of mothers with epilepsy. Epilepsia 2007; 48:2234-2240.
65. Glover SJ, Quinn AG, Barter P e t al . Ophthalmic fi ndings in fetal anticonvulsant syndrome(s). Ophthalmology 2002; 109:942-947.
66. Schou M, Amdisen A, Steenstrup OR. Lithium and pregnancy. II. hazards to women given lithium during pregnancy and delivery. Br Med J 1973; 21:137-138.
67. Kallen B. Comments on teratogen update: lithium. Teratology 1988; 38:597.
68. Schou M. What happened later to the lithium babies? A follow-up study of children born without malformations. Acta Psychiatr Scand 1976; 54:193-197.
69. Schou M, Goldfi eld MD, Weinstein MR, Villeneuve A. Lithium and pregnancy. I. Report from the Register of Lithium Babies. Br Med J 1973; 2:135-136.
70. Weinstein MR. The international register of lithium babies. D rug Inf J 1976; 10:94-100.
71. Weinstein MR, Goldfi eld M. Cardiovascular malformations with lithium use during pregnancy. Am J Psychiatry 1975; 132:529-531.
72. Zalzstein E, Koren G, Einarson T, Freedom RM. A case- control study on the association between fi rst trimester exposure to lithium and Ebstein ' s anomaly. Am J Cardiol 1990; 65:817-818.
73. Jacobson SJ, Jones K, Johnson K e t al . Prospective multicentre study of pregnancy outcome after lithium exposure during fi rst trimester. Lancet 1992; 339:530-533.
74. Troyer WA, Pereira GR, Lannon RA, Belik J, Yoder MC. Association of maternal lithium exposure and premature delivery. J Perinatol 1993; 13:123-127.
75. Kallen B, Tandberg A. Lithium and pregnancy. A cohort study on manic-depression. Acta Psychiatr Scand 1983; 68:134-139.
76. Edmonds LD, Oakley GP, Jr. Ebstein ' s nomaly and maternal lithium exposure during pregnancy. Teratology 1990; 41:551-552.
77. Grover S, Gupta N. Lithium associated anencephaly. Can J Psych 2005; 50:185-186.
78. Cohen L, Friedman JM, Jefferson JW, Johnson EM, Weiner ML. A re-evaluation of risk of in utero exposure to lithium. JAMA 1994; 271:146-150. (Pubitemid 24020593)
79. Meador KJ, Pennell PB, Harden CL e t al . Pregnancy registries in epilepsy. A consensus statement on health outcomes. Neurology 2008; 71:1109-1117.
80. Kjaer D, Horvath-Puho E, Christensen J, Vestergaard M, Czeizel A, Sorenesen HT. Antiepileptic drug use, folic acid supplementation and congenital abnormalities: a population-based case - control study. Br J Obstetn Gynaecol 2008; 115:98-103.
81. Galbally M, Snellen M, Walker SP, Permezel M. Management of antipsychotic and mood stabiliser medication in pregnancy: recommendations for antenatal care. Aust N Z J Psychiatry 2010; 44:99-108.
82. Radford DJ, Graff RF, Neilson GH. Diagnosis and natural history of Ebstein ' s anomaly. Br Heart J 1985; 54:517-522.
83. Yonkers KA, Wisner KL, Stowe Z et al . Management of bipolar disorder during pregnancy and the postpartum period. Am J Psychiatry 2004; 161:608-620.
84. Bilszta J, Galbally M, Buist A. Bipolar disorder and puerperal psychosis in pregnancy and the postpartum: managing sleep and medication. In: Hansson W, Olsson E, eds. New Perspectives on Women and Depression. New York: Nova, 2008:109-132.
85. Henshaw SK. Unintended pregnancy in the United States. F am Plann Perspect 1998; 30:24-29.
86. Coverdale J, Falloon I, Turbott S. Sexually transmitted disease and family planning counselling of psychiatric patients in New Zealand. Aust N Z J Psychiatry 1997; 31:285-290.
87. Jablensky AV, Morgan V, Zubrick SR, Bower C, Yellachich LA. Pregnancy, delivery, and neonatal complications in a population cohort of women with schizophrenia and major affective disorders. Am J Psychiatry 2005; 162:79-91.
88. Riordan D, Appleby L, Faragher B. Mother - infant interaction in post-partum women with schizophrenia and affective disorders. Psychol Med 1999; 29:991-995.
89. Murray L, Sinclair D, Cooper P, Ducournau P, Turner P, Stein A. The socioemotional development of 5-year-old children of postnatally depressed mothers. J Child Psychol Psychiatry 1999; 40:1259-1271.
90. Murray L, Hipwell A, Hooper R, Stein A, Cooper P. The cognitive development of 5-year-old children of postnatally depressed mothers. J Child Psychol Psychiatry 1996; 37:927-935.
91. Nilsson E, Hultman CM, Cnattingius S, Olausson PO, Bjork C, Lichtenstein P. Schizophrenia and offspring ' s risk for adverse pregnancy outcomes and infant death. Br J Psychiatry 2008; 193: 311-315.
92. Bennedsen BE, Mortensen PB, Olesen AV, Henriksen TB. Pretermbirth and intra-uterine growth retardation among children of mothers with Schizophrenia. Br J Psychiatry 1999; 175:239-245.